Physician
Osama Naga MD PA
Osama Naga MD PA was paid $5.07M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoOSAMA NAGA MD PA
EL PASO, TX 79902
EL PASO, TX 79902
33aNPI1396080867assigned 12/10/2012
33bProvider typePediatrics Physician
28Total paid$5.07M
24GClaims153,860
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#79 of 1,136
Median peer was paid$329K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,338 | $97K | |
| 2019 | 4,240 | $155K | |
| 2020 | 5,869 | $196K | |
| 2021 | 24,523 | $748K | |
| 2022 | 39,687 | $1.16M | |
| 2023 | 38,435 | $1.30M | |
| 2024incomplete | 38,768 | $1.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 42,181 | 32,689 | $2.11M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.3% | 4,149 | 4,087 | $369K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.4% | 3,610 | 3,512 | $327K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.0% | 7,427 | 6,845 | $306K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.0% | 20,099 | 9,102 | $305K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.0% | 3,071 | 2,876 | $254K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.8% | 2,093 | 2,045 | $193K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.6% | 2,321 | 2,168 | $184K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.3% | 11,840 | 11,021 | $169K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.2% | 7,976 | 3,766 | $112K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.1% | 1,495 | 1,449 | $108K |
| 99050 | 1.9% | 8,996 | 7,972 | $97K |
47 more codes
| 90670 | 1.7% | 2,059 | $86K | |
| 99499 | 1.6% | 1,181 | $82K | |
| 90461 | <1% | 5,041 | $50K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,277 | $41K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,720 | $37K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 612 | $32K |
| 90651 | <1% | 888 | $23K | |
| 90681 | <1% | 1,171 | $19K | |
| 99381 | <1% | 172 | $17K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,428 | $16K |
| 99460 | <1% | 250 | $14K | |
| 90700 | <1% | 1,437 | $14K | |
| 90686 | <1% | 3,321 | $12K | |
| 99051 | <1% | 350 | $11K | |
| 99383 | <1% | 53 | $7K | |
| 90713 | <1% | 611 | $7K | |
| 0071A | <1% | 166 | $6K | |
| 90633 | <1% | 1,342 | $6K | |
| 0072A | <1% | 159 | $6K | |
| 90648 | <1% | 1,389 | $6K | |
| 99429 | <1% | 186 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 39 | $5K |
| 90716 | <1% | 327 | $5K | |
| 99384 | <1% | 30 | $4K | |
| 90619 | <1% | 344 | $4K | |
| 96160 | <1% | 1,804 | $4K | |
| 90734 | <1% | 168 | $4K | |
| 90620 | <1% | 280 | $3K | |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | <1% | 132 | $3K |
| 90707 | <1% | 319 | $3K | |
| 81002 | <1% | 834 | $2K | |
| 90715 | <1% | 263 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 13 | $956.21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,577 | $686.98 |
| 90744 | <1% | 153 | $673.47 | |
| 90677 | <1% | 446 | $577.32 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 362 | $522.27 |
| 90710 | <1% | 700 | $322.86 | |
| 90685 | <1% | 13 | $264.42 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 77 | $172.13 |
| 96127 | <1% | 70 | $37.73 | |
| 90723 | <1% | 448 | $0.42 | |
| 90696 | <1% | 251 | $0.16 | |
| 90697 | <1% | 714 | $0.10 | |
| 91307 | <1% | 325 | $0.07 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 76 | $0.00 |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNAGA, OSAMA (PRESIDENT)